Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts

European Journal of Immunology

Volumn 28, Issue 1, 1998, Pages 122-133

  Seliger, Barbara ^a   Harders, Christina ^a   Lohmann, Sabine ^a   Momburg, Frank ^b   Urlinger, Stefanie ^c   Tampé, Robert ^c,d   Huber, Christoph ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antigen processing; Low molecular weight proteins; MHC; Ras oncogene; TAP

Indexed keywords

BETA 2 MICROGLOBULIN; COMPLEMENTARY DNA; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; PROTEASOME;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL STRAIN 3T3; CELL SURFACE; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA TRANSFECTION; FIBROBLAST; GENE FUNCTION; LYMPHOCYTE CULTURE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; ATP-BINDING CASSETTE TRANSPORTERS; BETA 2-MICROGLOBULIN; CELL TRANSFORMATION, NEOPLASTIC; COLD; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MHC CLASS I; GENES, RAS; GENETIC COMPLEMENTATION TEST; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON-GAMMA, RECOMBINANT; MICE; MULTIENZYME COMPLEXES; NEOPLASM PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BIOSYNTHESIS; PROTEINS; RATS; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 0031964480     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199801)28:01<122::AID-IMMU122>3.0.CO;2-F     Document Type: Article

References (52)

1. Zinkernagel, R. and Doherty, P. C., MHC restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction, function and responsiveness. Adv. Immunol. 1979. 22: 51-77.
2. Goodenow, R. S., Vogel, J. M. and Linsk, R. L., Histo-compatibility antigens on murine tumors. Science 1985. 230: 777-783.
3. Elliot, B. E., Carlow, D. A., Rodricks, A. and Wade, A., Perspectives on the role of MHC antigens in normal malignant cell development. Adv. Cancer Res. 1989. 53: 181-245.
4. Plata, F., Tilkin, A. F., Levy, J. P. and Lilly, F., Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells affect the H-2 restriction patterns of tumor-specific cytotoxic T-lymphocytes. J. Exp. Med. 1981. 184: 1795-1810.
5. Garrido, F., Cabrera, T., Concha, A., Glew, S., Ruiz-Cabello, F. and Stern, P. L., Natural history of HLA expression during tumor development. Immunol. Today 1993. 14: 491-499.
6. Ferrone, S. and Marincola, F. M., Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today 1995. 16: 487-494.
7. Wölfel, T., Klehmann, E., Müller, C., Schutt, K. H., Meyer zum Büschenfelde, K.-H. and Knuth, A., Lysis of melanoma cells by autologous cytolytic T cell clones: identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens. J. Exp. Med. 1989. 170: 797-810.
8. Tanaka, K., Isselbacher, A., Khoury, G. and Jay, G., Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene. Science 1985. 228: 26-30.
9. Hämmerling, G. J., Klar, D., Pulm, W., Momburg, F. and Moldenhauer, G., The influence of MHC class I antigens on tumor growth and metastasis. Biochim. Biophys. Acta 1987. 179: 245-259.
10. Weis, J. H. and Seidman, J. G., The expression of major histocompatibility antigen under metallothionin gene promoter control. J. Immunol. 1985. 134: 1999-2004.
11. Cromme, F. V., Airey, J., Heemels, M. T., Ploegh, H., Keating, P. J., Stern, P. L., Meijer, C. J. L. M. and Walboomers, J. M. M., Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J. Exp. Med. 1994. 179: 335-340.
12. Kaklamanis, L., Leek, R., Koukourakis, M., Gatter, K. C. and Harris, A. L., Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in primary and metastatic versus primary breast cancer. Cancer Res. 1995. 55: 5191-5194.
13. Hicklin, D. J., Kageshita, T., Dellaratta, D. V., Boccaletti, V. and Ferrone, S., Defects in HLA class I antigen presentation machinery in melanoma cells. In Maio, M. (Ed.) Immunology of human melanoma. IOS Press, Amsterdam, The Netherlands 1996, pp 95-111.
14. Restifo, N. P., Esquivel, F., Kawakami, Y., Mule, J. J., Rosenberg, S. A. and Bennink, J. R., Identification of human cancers deficient in antigen processing. J. Exp. Med. 1993. 177: 265-272.
15. Rowe, M., Khanna, R., Jacob, C. A., Argaet, V., Kelly, A., Powis, S., Belich, M., Croom-Carter, D., Lee, S., Burrows, S. R., Trowsdale, J., Moss, D. J. and Rickinson, A. B., Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA class I antigen expression. Eur. J. Immunol. 1995. 25: 1374-1384.
16. Sanda, M. G., Restifo, N. P., Walsh, J. C., Kawakami, Y., Nelson, W. G., Pardoll, D. M. and Simons, J. W., Molecular characterization of defective antigen processing in human prostate cancer. J. Natl. Cancer Inst. 1995. 87: 280-285.
17. Maeurer, M. J., Gollin, S. M., Storkus, W. J., Swaney, W., Martin, D., Karbach, J., Castelli, C., Salter, R., Knuth, A. and Lotze, M. T., Tumor escape from immune recognition: Loss of HLA-A2 melanoma cell surface expression associated with a complex rearrangement of the short arm of chromosome 6. Clin. Cancer Res. 1996. 2: 641-647.
18. Seliger, B., Höhne, A., Knuth, A., Bernhard, H., Meyer, T. H., Tampe, R., Momburg, F. and Huber, C., Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression. Cancer Res. 1996. 56: 1756-1760.
19. Seliger, B., Höhne, A., Knuth, A., Bernhard, H., Ehring, B., Tampé, R. and Huber, C., Reduced membrane MHC class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression. Clin. Cancer Res. 1996. 2: 1427-1433.
20. Schrier, P. I., Bernards, R., Vaessen, R. M. M. J., Houweling, A. and van der Eb, A. J., Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature 1983. 305: 771-776.
21. Eager, K., Williams, J., Breiding, D., Pans, S., Knowles, B., Appella, E. and Riccardi, R. P., Expression of histocompatibility antigens H-2K, -D and L is reduced in adenovirus 12 transformed mouse cells and is restored by IFN. Proc. Natl. Acad. Sci. USA 1985. 82: 5525-5529.
22. Rotem-Yehudar, R., Groettrup, M., Soza, A., Kloetzel, P. and Ehrlich, R., LMP-associated proteolytic activities and TAP-dependent peptide transport for class I MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12. J. Exp. Med. 1996. 183: 499-514.
23. Rotem-Yehudar, R., Winograd, S., Sela, S., Coligan, J. E. and Ehrlich, R., Downregulation of peptide transporter genes in cell lines transformed with highly oncogenic adenovirus 12. J. Exp. Med. 1994. 180: 477-488.
24. Mausdley, D. J. and Pond, J. S., Modulation of MHC antigen expression by viruses and oncogenes. Immunol. Today 1991. 12: 429-431.
25. Bernards, R., Dessain, S. K. and Weinberg, R. A., N-myc amplification causes downmodulation of MHC class I antigen expression in neuroblastoma. Cell 1986. 47: 667-672.
26. Versteeg, R., Nordermeer, I. A., Kruse-Wolters, M., Ruiter, D. J. and Schrier, P. I., C-myc downregulates class I HLA expression in human melanomas. EMBO J. 1988. 7: 1923-1929.
27. Seliger, B. and Pfizenmaier, K., Post-transcriptional downregulation of MHC class I expression in oncogene-transformed cells is reverted by IFN-alpha and -gamma. J. Immunogenet. 1989. 16: 315-320.
28. Gogusev, J. B., Teutsch, B., Morin, T. M., Mongiat, R, Haguenau, F., Suskind, J. and Rabotti, G. F., Inhibition of HLA class I antigen and mRNA expression induced by Rous sarcoma virus in transformed fibroblasts. Proc. Natl. Acad. Sci. USA 1988. 85: 203-207.
29. Howcroft, T. K., Richardson, J. C. and Singer, D. S., MHC class I gene expression is negatively regulated by the protooncogene c-jun. EMBO J. 1993. 12: 3163-3169.
30. Ottensen, S. S., Skouv, J. and Kieler, J., Reduced HLA-A, -B, -C expression in tumorigenic v-raf transfected human urothelial cells. Eur. J. Cancer 1990. 26: 305-310.
31. Lu, J. J., Blair, D. G., Segal, S., Shih, T. Y. and Clanton, D. J., Tumorigenicity, metastasis and suppression of MHC class I expression in murine fibroblasts transformed by mutant v-ras deficient in GTP-binding. Int. J. Cancer [Suppl] 1991. 6: 45-53.
32. Solana, R., Romero, J., Alonso, C. and Pena, J., MHC class I antigen expression is inversely related with tumor malignancy and ras oncogene product (p21) levels in human breast tumors. Invasion Metastasis 1992. 12: 210-217.
33. Ackrill, A. M. and Blair, E., Regulation of major histocompatibility class I antigen expression at the level of transcription in highly oncogenic adenovirus transformed rat cells. Oncogene 1988. 3: 483-487.
34. Meijer, I., Jochemsen, A. G., de Witt, C. M., Bos, J. L., Morello, D. and Van der Eb, A. J., Adenovirus type 12 E1a down regulates expression of a transgene under control of a major histocompatibility complex class I promoter: evidence for transcriptional control. J. Virol. 1989. 9: 4039-4042.
35. Shemesh, J., Rotem-Yehudar, R. and Ehrlich, R., Transcriptional and posttranscriptional regulation of class I major histocompatibility complex genes following infection and transformation with human adenoviruses. J. Virol. 1991. 65: 5544-5548.
36. Vaessen, R. T. M. J., Houweling, A. and Van der Eb, A. J., Posttranscriptional control of class I MHC mRNA expression in adenovirus 12-transformed cells. Science 1987. 235: 1486-1488.
37. Lohmann, S., Wollscheid, U., Huber, C. and Seliger, B., Multiple levels of MHC class I down-regulation by ras oncogenes. Scand. J. Immunol. 1996. 43: 537-544.
38. Ljunggren, H. G., Stam, N. J., Öhlen, C., Neefjes, J. J., Höglund, P., Heemels, M. T., Bastin, J., Schumacher, T. N. M., Townsend, A., Kärre, K. and Ploegh, H. L., Empty MHC class I molecules come out in the cold. Nature 1990. 346: 476-480.
39. Wright, K. L., White, L. C., Kelly, A., Beck, S., Trowsdale, J. and Ting, J. P.-Y., Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J. Exp. Med. 1995. 181: 1459-1471.
40. Seliger, B., Kruppa, G., Schäfer, R., Redmond, S. H. and Pfizenmaier, K., Gamma interferon regulates long terminal repeat-controlled oncogene expression in transformed mouse fibroblasts at the level of mRNA transcription. J. Virol. 1988. 62: 619-621.
41. Ljunggren, H. G. and Kärre, K., Host resistance directed selectively against H-2 deficient lymphoma variants. J. Exp. Med. 1985. 162: 1745-1749.
42. Engelhard, V. H., Structure of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 1994. 6: 13-23.
43. Wölfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Meyer zum Büschenfelde, K.-H. and Boon, T., Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T-lymphocytes. Eur. J. Immunol. 1994. 24: 759-764.
44. Chirgwin, J. M., Przybyla, A. E., Mac Donald, R. J. and Rutter, W., Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. J. Biochem. 1979. 18: 5294-5299.
45. Monaco, J. J., Cho, S. and Attaya, M., Transport protein genes in the murine MHC: possible implications for antigen processing. Nature 1990. 250: 1723-1726.
46. Yang, Y., Früh, K., Chambers, J., Waters, J. B., Wu, L., Spies, T. and Peterson, P. A., Major histocompatibility complex (MHC)-encoded HAM2 is necessary for antigenic peptide loading onto class I MHC molecules. J. Biol. Chem. 1992. 267: 11669-11672.
47. Martinez, C. K. and Monaco, J. J., Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene. Nature 1991. 353: 664-667.
48. Towbin, H. S., Staehelin, J. and Gordon, J., Electro-phoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 1979. 76: 4344-4350.
49. Meyer, T. H., van Endert, P. M., Uebel, S., Ehring, B. and Tampé, R., Functional expression and purification of the transporter associated with antigen processing in insect cells. FEBS Lett. 1994. 351: 443-447.
50. Ahn, K., Meyer, T. H., Uebel, S., Sempé, P., Dhaballah, H., Yang, Y., Peterson, P. A., Früh, K. and Tampé, R., Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 1996. 15: 3247-3255.
51. Früh, K., Young, Y., Arnold, D., Chambers, J., Wu, L., Waters, J. B., Spies, T. and Peterson, P. A., Alternative exon usage and processing of the major histocompatibility complex-encoded proteasome subunits. J. Biol. Chem. 1992. 267: 22131-22140.
52. Neefjes, J. J., Momburg, F. and Hämmerling, G. J., Selective and ATP-dependent translocation of peptides by MHC-encoded transporter. Science 1993. 261: 769-771.